Liquid Dosage
As a result of growing competition and more stringent regulatory requirements for end-user safety, improving the convenience and ease of administration of parenteral therapeutics is becoming a common strategy for biotechnology and pharmaceutical companies. Manufacturers wishing to gain market share and provide high quality products for healthcare professionals and cancer patients alike are increasingly investing in the development and delivery of liquid dosage forms, freeze-dried products and injectables.
GEA is known all over the world for its individual and tailor-made process plant for the manufacture of free-flowing pharmaceutical and biotechnology products. Complete plant, modular equipment, process units and skids can be assembled, tested and qualified in our own production facilities. We perform tests and trial runs with appropriate media to demonstrate the functionality of all components and equipment before the plant is delivered.
In collaboration and partnership with our customers, we aim to develop and deliver high-performance plant and economic process systems that comply with the highest operational safety and environmental standards; we want our customers to use our groundbreaking solutions to manufacture even better products in the future.
GEA can supply a specialized, contained and fully integrated system when no standard off-the-shelf one exists, particularly for toxic or highly potent drugs such as cytostatics or echo contrast media. With our innovative ideas and fresh approaches, together with your project team, we will find a solution that’s tailored to your needs — from basic engineering to fabrication and qualification.
Mostrar 4 de 8

GEA Hilge ofrece una gama versátil de bombas centrífugas y de desplazamiento positivo para una amplia variedad de aplicaciones sensibles en las industrias de bebidas, alimentaria y farmacéutica.

GEA's thorough understanding of the lyophilization process enables them to supply a comprehensive range of products and services, comprising laboratory equipment, pilot plants for research and small-scale production batches, industrial size pharmaceutical production freeze dryers.

GEA's versatile range of R&D drying & particle processing equipment - for advanced powder processing within food and dairy products, chemicals and pharmaceuticals.

Los separadores de GEA están diseñados para aplicaciones a base de líquidos. Utilizan fuerza centrífuga y se emplean para separar suspensiones que consisten de dos o más fases de distinta densidad; por ejemplo, pueden separar líquido-líquido, líquido-líquido-sólido o líquido-sólido. También son eficaces para separar mezclas líquidas a la vez que ...
Whether it’s a fad or the future, 100% vial traceability is becoming an increasingly important consideration in the pharmaceutical freeze drying industry. Keeping a close eye on developments is GEA. We’re investigating possible solutions and, what’s more, we have the experience, expertise and know-how to implement them.
Hubo un tiempo en que nunca se mencionaban juntas la ‘cerveza sin alcohol’ y las ‘comidas sabrosas’, particularmente por los propios consumidores. Pero las cervezas de baja graduación alcohólica y sin alcohol han recorrido un largo camino —ahora muchas de ellas son refrescos de pleno derecho— gracias en última instancia a la tecnología de GEA.
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.